2023

We have adopted a nationwide business model, successively establishing "Guangxi Zhongke Jingyan Medical Technology Co., Ltd." and "Hunan Zhongke Jingyan Medical Technology Co., Ltd." This year, we also collaborated with Soochow University on the research and development of bio-synthetic protein medical materials, including the research and analysis of succinylated globulin, fibronectin, mucosal protein, recombinant collagen, recombinant silk fibroin, recombinant mussel protein, bioenzymes, and biopeptides. Driven by various positive factors, the company achieved remarkable results in 2023, with sales exceeding 30 million. This achievement marks a new stage in our business development.

Sorry,当前栏目暂无内容!

您可以查看其他栏目或返回 首页

Sorry,The current column has no content!

You can view other columns or return Home

Get a Quote

Get a Quote

You can submit your information online, and we will reply to you within 24 hours.

%{tishi_zhanwei}%